SE0004124D0 - New use - Google Patents

New use

Info

Publication number: SE0004124D0
Authority: SE; Sweden
Prior art keywords: dsm; reducing; lactobacillus plantarum; lactobacillus; new use
Prior art date: 2000-11-10

Application number

SE0004124A

Other languages

English (en)

Swedish (sv)

Inventor

Marie-Louise Johansson

Marek Naruszewicz

Original Assignee

Probi Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-10

Filing date

2000-11-10

Publication date

2000-11-10

2000-11-10 Application filed by Probi Ab filed Critical Probi Ab

2000-11-10 Priority to SE0004124A priority Critical patent/SE0004124D0/xx

2000-11-10 Publication of SE0004124D0 publication Critical patent/SE0004124D0/xx

2001-11-12 Priority to NZ525657A priority patent/NZ525657A/en

2001-11-12 Priority to CA2434035A priority patent/CA2434035C/fr

2001-11-12 Priority to EP01983031A priority patent/EP1331938B1/fr

2001-11-12 Priority to DK01983031T priority patent/DK1331938T3/da

2001-11-12 Priority to AT01983031T priority patent/ATE343392T1/de

2001-11-12 Priority to KR1020087011377A priority patent/KR20080047628A/ko

2001-11-12 Priority to DE60124131T priority patent/DE60124131T2/de

2001-11-12 Priority to US10/416,184 priority patent/US20040048356A1/en

2001-11-12 Priority to JP2002540747A priority patent/JP4200518B2/ja

2001-11-12 Priority to PL362221A priority patent/PL203824B1/pl

2001-11-12 Priority to CNB018218849A priority patent/CN1226039C/zh

2001-11-12 Priority to KR1020037006309A priority patent/KR100886728B1/ko

2001-11-12 Priority to ES01983031T priority patent/ES2269480T3/es

2001-11-12 Priority to AU2002214486A priority patent/AU2002214486B2/en

2001-11-12 Priority to AU1448602A priority patent/AU1448602A/xx

2001-11-12 Priority to PCT/SE2001/002500 priority patent/WO2002038165A1/fr

2003-05-08 Priority to NO20032056A priority patent/NO330992B1/no

Links

QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
240000006024 Lactobacillus plantarum Species 0.000 abstract 2
235000013965 Lactobacillus plantarum Nutrition 0.000 abstract 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
229940072205 lactobacillus plantarum Drugs 0.000 abstract 2
206010020772 Hypertension Diseases 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
108010007622 LDL Lipoproteins Proteins 0.000 abstract 1
241000186660 Lactobacillus Species 0.000 abstract 1
102000016267 Leptin Human genes 0.000 abstract 1
108010092277 Leptin Proteins 0.000 abstract 1
208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
210000001072 colon Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
229940039696 lactobacillus Drugs 0.000 abstract 1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 abstract 1
229940039781 leptin Drugs 0.000 abstract 1
235000019260 propionic acid Nutrition 0.000 abstract 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Plant Substances (AREA)

SE0004124A 2000-11-10 2000-11-10 New use SE0004124D0 (sv)

Priority Applications (18)

Application Number	Priority Date	Filing Date	Title
SE0004124A SE0004124D0 (sv)	2000-11-10	2000-11-10	New use
PCT/SE2001/002500 WO2002038165A1 (fr)	2000-11-10	2001-11-12	Utilisation d'une souche de lactobacillus reduisant les facteurs de risque associes au syndrome metabolique
US10/416,184 US20040048356A1 (en)	2000-11-10	2001-11-12	Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
PL362221A PL203824B1 (pl)	2000-11-10	2001-11-12	Zastosowanie szczepu Lactobacillus plantarum
EP01983031A EP1331938B1 (fr)	2000-11-10	2001-11-12	Utilisation d'une souche de lactobacillus reduisant les facteurs de risque associes au syndrome metabolique
DK01983031T DK1331938T3 (da)	2000-11-10	2001-11-12	Anvendelse af en stamme af Lactobacillus til reduktion af risikofaktorer forbundet med det metaboliske syndrom
AT01983031T ATE343392T1 (de)	2000-11-10	2001-11-12	Verwendung eines lactobacillus-stammes zur verringerung der risikofaktoren im zusammenhang mit dem metabolischen syndrom
KR1020087011377A KR20080047628A (ko)	2000-11-10	2001-11-12	대사 증후군에 관련된 위험인자를 감소시키기 위한락토바실러스 균주 포함 약물
DE60124131T DE60124131T2 (de)	2000-11-10	2001-11-12	Verwendung eines lactobacillus-stammes zur verringerung der risikofaktoren im zusammenhang mit dem metabolischen syndrom
NZ525657A NZ525657A (en)	2000-11-10	2001-11-12	Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
JP2002540747A JP4200518B2 (ja)	2000-11-10	2001-11-12	代謝症候群に関与する危険因子を減少するＬａｃｔｏｂａｃｉｌｌｕｓ株の使用
CA2434035A CA2434035C (fr)	2000-11-10	2001-11-12	Utilisation d'une souche de lactobacillus reduisant les facteurs de risque associes au syndrome metabolique
CNB018218849A CN1226039C (zh)	2000-11-10	2001-11-12	乳杆菌属菌株在减少代谢综合征危险因子中的应用
KR1020037006309A KR100886728B1 (ko)	2000-11-10	2001-11-12	대사 증후군에 관련된 위험인자를 감소시키기 위한 락토바실러스 균주 포함 약물
ES01983031T ES2269480T3 (es)	2000-11-10	2001-11-12	Uso de una cepa de lactobacillus que reduce los factores de riesgo asociados al sindrome metabolico.
AU2002214486A AU2002214486B2 (en)	2000-11-10	2001-11-12	Use of a strain of Lactobacillus reducing the risk factors involved in the metabolic syndrome
AU1448602A AU1448602A (en)	2000-11-10	2001-11-12	Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
NO20032056A NO330992B1 (no)	2000-11-10	2003-05-08	Anvendelse av en stamme av Lactobacillus som reduserer risikofaktorer som er involvert i metabolsk syndrom

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0004124A SE0004124D0 (sv)	2000-11-10	2000-11-10	New use

Publications (1)

Publication Number	Publication Date
SE0004124D0 true SE0004124D0 (sv)	2000-11-10

Family

ID=20281779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0004124A SE0004124D0 (sv)	2000-11-10	2000-11-10	New use

Country Status (16)

Country	Link
US (1)	US20040048356A1 (fr)
EP (1)	EP1331938B1 (fr)
JP (1)	JP4200518B2 (fr)
KR (2)	KR100886728B1 (fr)
CN (1)	CN1226039C (fr)
AT (1)	ATE343392T1 (fr)
AU (2)	AU2002214486B2 (fr)
CA (1)	CA2434035C (fr)
DE (1)	DE60124131T2 (fr)
DK (1)	DK1331938T3 (fr)
ES (1)	ES2269480T3 (fr)
NO (1)	NO330992B1 (fr)
NZ (1)	NZ525657A (fr)
PL (1)	PL203824B1 (fr)
SE (1)	SE0004124D0 (fr)
WO (1)	WO2002038165A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002526413A (ja) *	1998-10-01	2002-08-20	プロビエービー	酸化性ストレス因子の減少
CN1293185C (zh) *	2002-10-30	2007-01-03	食品工业发展研究所	具有降低与同化胆固醇能力的新颖耐酸与耐胆盐乳杆菌分离株
CN1237168C (zh) *	2002-10-30	2006-01-18	食品工业发展研究所	具有降低与同化胆固醇能力的耐酸与耐胆盐乳杆菌分离株
CN1293186C (zh) *	2002-10-30	2007-01-03	食品工业发展研究所	具有降低与同化胆固醇能力的新颖耐酸与耐胆盐乳杆菌分离株
CN1293187C (zh) *	2002-10-30	2007-01-03	食品工业发展研究所	具有降低与同化胆固醇能力的新颖耐酸与耐胆盐乳杆菌分离株
SE527555C2 (sv)	2003-04-04	2006-04-11	Probi Ab	Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
JP5363811B2 (ja)	2005-09-28	2013-12-11	ノルディスクリバランスアクティーゼルスカブ	治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるｉｂｄ及びｉｂｓの治療
RU2008134892A (ru)	2006-01-27	2010-03-10	Даниско А/С (Dk)	Применение пробиотичеких микроорганизмов для лечения и профилактики ожирения и связанных с ним расстройств
JP5229977B2 (ja) *	2006-09-08	2013-07-03	雪印メグミルク株式会社	血中アディポネクチン濃度増加促進及び／又は減少抑制剤
JP5201832B2 (ja) *	2006-12-25	2013-06-05	花王株式会社	脂肪分解促進用皮膚外用剤
JP2008214253A (ja)	2007-03-02	2008-09-18	Snow Brand Milk Prod Co Ltd	内臓脂肪減少剤
SE532899C2 (sv)	2007-06-08	2010-05-04	Probi Ab	Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
EP2011506A1 (fr) *	2007-07-05	2009-01-07	Nestec S.A.	Supplémentation de régime maternel
KR101010914B1 (ko) *	2008-04-28	2011-01-26	주식회사 엔유씨전자	항비만 및 뇌기능개선 관련 생리활성 기능을 가지는 프로바이오틱 유산균 락토바실러스 플란타늄
CN102448477A (zh)	2009-03-25	2012-05-09	科·汉森有限公司	益生菌在调节体重中的用途
WO2010146568A2 (fr)	2009-06-19	2010-12-23	Danisco A/S	Bifidobactéries pour le traitement du diabète et d'affections apparentées
CA2784723C (fr)	2009-12-22	2021-01-12	Probi Ab	Compositions non fermentees comprenant une fraction a base de cereales et un probiotique et des utilisations de celles-ci
KR101426276B1 (ko) *	2012-08-16	2014-08-05	주식회사한국야쿠르트	심장질환 및 뇌졸중을 유발하는 거품세포 형성 억제 및 혈관 병변 형성을 억제하는 활성을 가지는 락토바실러스 플란타룸 ｈｙ７７１２를 유효성분으로 함유하는 제품
KR101470995B1 (ko) *	2013-08-30	2014-12-09	주식회사 바이오리쏘스	프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
KR101500974B1 (ko) *	2014-08-22	2015-03-13	(주) 에이투젠	항염증 및 대사성질환 개선 효능을 가지는 락토바실러스 플란타룸 hac01 균주 및 이의 용도
CN105105145B (zh) *	2015-09-14	2022-04-22	吉林省命之元生物科技有限公司	一株植物乳杆菌及其在制备降血糖血脂的功能性食品中的应用
GB201519327D0 (en)	2015-11-02	2015-12-16	Optibiotix Health Ltd	Composition
CN105567601A (zh) *	2016-01-29	2016-05-11	江苏绿科生物技术有限公司	一种植物乳杆菌及其应用
WO2018145294A1 (fr)	2017-02-10	2018-08-16	Perfect (China) Co., Ltd.	Nouvelles souches de bifidobactéries probiotiques
WO2018216735A1 (fr) *	2017-05-26	2018-11-29	ハウスウェルネスフーズ株式会社	Composition pour la prévention, la régression ou le traitement du syndrome métabolique
KR102063772B1 (ko) *	2019-07-23	2020-01-08	주식회사 메디오젠	혈당 강하 효과 및 항산화 효과를 갖는 유산균
WO2022000077A1 (fr) *	2020-07-01	2022-01-06	Panag Pharma Inc.	Résidu de plant de cannabis et son utilisation
CN112126604B (zh) *	2020-09-30	2022-05-17	江南大学	一株可降低高血压发生风险因子的植物乳杆菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9501056D0 (sv) *	1995-03-23	1995-03-23	Probi Ab	Epithelial adherent lactobacilli
SE510753C2 (sv) *	1997-08-05	1999-06-21	Probi Ab	Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
US6589969B1 (en) *	1998-10-16	2003-07-08	Ono Pharmaceutical Co., Ltd.	Carboxylic acid derivatives and drugs containing the same as the active ingredient

2000
- 2000-11-10 SE SE0004124A patent/SE0004124D0/xx unknown
2001
- 2001-11-12 EP EP01983031A patent/EP1331938B1/fr not_active Expired - Lifetime
- 2001-11-12 DK DK01983031T patent/DK1331938T3/da active
- 2001-11-12 WO PCT/SE2001/002500 patent/WO2002038165A1/fr not_active Ceased
- 2001-11-12 AU AU2002214486A patent/AU2002214486B2/en not_active Expired
- 2001-11-12 CN CNB018218849A patent/CN1226039C/zh not_active Expired - Lifetime
- 2001-11-12 KR KR1020037006309A patent/KR100886728B1/ko not_active Expired - Lifetime
- 2001-11-12 CA CA2434035A patent/CA2434035C/fr not_active Expired - Lifetime
- 2001-11-12 ES ES01983031T patent/ES2269480T3/es not_active Expired - Lifetime
- 2001-11-12 US US10/416,184 patent/US20040048356A1/en not_active Abandoned
- 2001-11-12 KR KR1020087011377A patent/KR20080047628A/ko not_active Ceased
- 2001-11-12 NZ NZ525657A patent/NZ525657A/en not_active IP Right Cessation
- 2001-11-12 PL PL362221A patent/PL203824B1/pl unknown
- 2001-11-12 AU AU1448602A patent/AU1448602A/xx active Pending
- 2001-11-12 AT AT01983031T patent/ATE343392T1/de active
- 2001-11-12 DE DE60124131T patent/DE60124131T2/de not_active Expired - Lifetime
- 2001-11-12 JP JP2002540747A patent/JP4200518B2/ja not_active Expired - Fee Related
2003
- 2003-05-08 NO NO20032056A patent/NO330992B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU1448602A (en)	2002-05-21
CA2434035A1 (fr)	2002-05-16
JP2004520276A (ja)	2004-07-08
DK1331938T3 (da)	2007-02-12
NO20032056D0 (no)	2003-05-08
CA2434035C (fr)	2011-06-07
PL203824B1 (pl)	2009-11-30
ES2269480T3 (es)	2007-04-01
JP4200518B2 (ja)	2008-12-24
NZ525657A (en)	2005-05-27
AU2002214486B2 (en)	2007-04-26
DE60124131T2 (de)	2007-03-29
EP1331938A1 (fr)	2003-08-06
DE60124131D1 (de)	2006-12-07
KR20040018304A (ko)	2004-03-03
CN1486189A (zh)	2004-03-31
NO330992B1 (no)	2011-09-05
CN1226039C (zh)	2005-11-09
EP1331938B1 (fr)	2006-10-25
US20040048356A1 (en)	2004-03-11
WO2002038165A1 (fr)	2002-05-16
NO20032056L (no)	2003-05-08
PL362221A1 (en)	2004-10-18
ATE343392T1 (de)	2006-11-15
KR20080047628A (ko)	2008-05-29
KR100886728B1 (ko)	2009-03-04

Publication	Publication Date	Title
SE0004124D0 (sv)	2000-11-10	New use
GB0213612D0 (en)	2002-07-24	Organic compounds
IL161154A0 (en)	2004-08-31	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BR9811825A (pt)	2000-08-15	Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
DK1349856T3 (da)	2005-10-17	Isoindolin-1-on-glucokinase-aktivatorer
WO2001096377A3 (fr)	2002-06-13	Vaccin contre les tremblements congenitaux du porc
NO20060416L (no)	2006-03-24	Ny anvendelse I
WO2002083879A3 (fr)	2002-12-12	Immunotherapie basee sur des cellules dendritiques
AU4553700A (en)	2000-11-10	Substitution infusion fluid and citrate anticoagulation
WO2004083369A3 (fr)	2005-01-20	Composition de fixation tissulaire
AU2002338852A1 (en)	2003-04-22	Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
WO2002044113A3 (fr)	2002-09-12	Utilisation de derives d'acide acetique(-)(3-halomethylphenoxy)(4-halophenyl) dans le traitement de la resistance a l'insuline, le diabete de type 2, l'hyperlipidemie et l'hyperuricemie
AU2096897A (en)	1997-09-22	Serum cholesterol lowering agent
BRPI0414979A (pt)	2006-11-21	preparação sólida
HK1042852A1 (zh)	2002-08-30	增强胰岛素反应的方法
Friedmann	2006	Escherich and escherichia
EP1421945A4 (fr)	2005-06-22	Absorbant/adsorbant d'acide biliaire
WO2003087325A3 (fr)	2004-04-15	Methodes et compositions de prevention et de traitement d'infections microbiennes
AU2001283199A1 (en)	2002-02-18	Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
WO2004072263A3 (fr)	2004-12-23	Acide nucleique et proteine correspondante dite 158p1d7, utiles pour le traitement et la detection de cancers de la vessie et autres
WO2003070017A3 (fr)	2003-12-31	Nouveaux produits a base de proteines de soja
WO2003032963A3 (fr)	2003-12-24	Methode de reduction du diabete type 2 chez des patients a risque eleve
EP1407783A4 (fr)	2004-07-21	Traitement d'une hernie
WO2004022059A3 (fr)	2004-09-30	Utilisation de 6 amino-quinoline-5, 8 quinones et acides nucleiques associes a la senescence en vue du traitement des tumeurs
WO2003070018A3 (fr)	2003-12-18	Produits alimentaires contenant des proteines de soja

SE0004124D0 - New use - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (18)

Applications Claiming Priority (1)

Publications (1)

Family

ID=20281779

Family Applications (1)

Country Status (16)

Families Citing this family (28)

Family Cites Families (3)

Also Published As

Similar Documents